Systemic Radiation Therapy Group
1 – 10 of 52
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Intratumoral Distribution of [177Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer
- Contribution to journal › Article
-
Mark
Heterogeneous Distribution and Absorbed Dose of Radiolabeled Nanoparticles and Colloids in Sentinel Lymph Nodes
- Contribution to journal › Article
-
Mark
Intratumoral distribution and pharmacokinetics of the radiolabeled ICAM-1 targeting monoclonal antibody R6.5 in a prostate cancer mouse model
- Contribution to journal › Article
-
Mark
Optimizing peptide nucleic acid-based pretargeting for enhanced targeted radionuclide therapy
- Contribution to journal › Article
- 2024
-
Mark
Feasibility of 177Lu activity quantification using a small portable CZT-based gamma-camera
- Contribution to journal › Article
-
Mark
A PBPK model for PRRT with [177Lu]Lu-DOTA-TATE : Comparison of model implementations in SAAM II and MATLAB/SimBiology
- Contribution to journal › Article
-
Mark
Investigating Ras homolog gene family member C (RhoC) and Ki67 expression following external beam radiation therapy show increased RhoC expression in relapsing prostate cancer xenografts
- Contribution to journal › Article
-
Mark
Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting
- Contribution to journal › Article
-
Mark
Relationship Between Absorbed Dose and Response in Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE
- Contribution to journal › Article
-
Mark
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate
- Contribution to journal › Article
